alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                                                                Exhibit 99


                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection  with the Quarterly  Report of Charles  Booth,  Inc. (the
"Company")  on Form 10-KSB for the year ending  December  31, 2002 as filed with
the Securities  and Exchange  Commission on the date hereof (the  "Report"),  I,
Dominic T. Martinez,  Chief Executive Officer and Chief Financial Officer of the
Company,  certify,  pursuant to 18 U.S.C.  Section  1350 as adopted  pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:

         (1) The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities and Exchange Act of 1934; and
         (2) The  information  contained in the Report fairly  presents,  in all
material  respects,  the  financial  condition  and result of  operations of the
Company.

         /s/ Dominic T. Martinez
---------------------------
         Dominic T. Martinez,
         Chief Executive Officer & Chief Financial Officer
EXHIBIT 3

Case 2:17-cv-04565-SMB Document 183-3 Filed 06/01/20 Page 1 of 4
Case 2:17-cv-04565-SMB Document 183-3 Filed 06/01/20 Page 2 of 4
Case 2:17-cv-04565-SMB Document 183-3 Filed 06/01/20 Page 3 of 4
Case 2:17-cv-04565-SMB Document 183-3 Filed 06/01/20 Page 4 of 4
Exhibit
32.1


CERTIFICATION




Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002


(Section
1350, Chapter 63 of Title 18, United States Code)




In
connection with the Quarterly Report of New Oriental Energy & Chemical Corp.
(the “Company”) on Form 10-Q for the period ended December 31, 2008, as filed
with the Securities Exchange Commission on the date hereof (the “Report”), I,
Chen Si Qiang, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. section 1350 , as adopted pursuant to section 906 of the Sarbanes-Oxley
Act of 2002, that:




(1)  The Report fully
complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and





(2)  The information
contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.





Date: February
      23, 2009By:
              /s/ Chen Si QiangChen
      Si QiangChief
      Executive Officer





A signed
original of this written statement required by Section 906 has been provided to
the Company and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

WO

IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF ARIZONA

United States of America,

Plaintiff,

v. 

Ethan Jacob Barlow,

Defendant.

No. CR-17-08318-01-PCT-DGC

ORDER

The defendant appeared in court with counsel. The defendant's probable cause 

hearing was waived, and the detention hearing was submitted on the record including a 

proffer by defense counsel. The Court finds probable cause to believe the defendant 

violated the terms of his supervised release as alleged in the petition. The Court further 

finds, pursuant to Rule 32.1(a)(6), that defendant has failed to show by clear and 

convincing evidence that he is not a flight risk or a danger.

IT IS HEREBY ORDERED that the defendant shall be bound over for further 

proceedings on the petition to revoke his supervised release.

IT IS FURTHER ORDERED that the defendant is detained as a flight risk and a 

danger, pending further revocation proceedings. 

Dated this 19th day of September, 2022.

Honorable Eileen S. Willett

United States Magistrate Judge

Case 3:17-cr-08318-DGC Document 37 Filed 09/19/22 Page 1 of 1
[Federal Register Volume 61, Number 104 (Wednesday, May 29, 1996)]
[Notices]
[Page 26917]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-13369]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Heart, Lung, and Blood Institute; Notice of Meeting

    Pursuant to Pub. L. 92-463, notice is hereby given of the meeting 
of the following Heart, Lung, and Blood Special Emphasis Panel.
    The meeting will be open to the public to provide concept review of 
proposed contract or grant solicitations.
    Individuals who plan to attend and need special assistance such as 
sign language interpretation or other reasonable accommodations, should 
inform the Contact Person listed below in advance of the meeting.

    Name of Panel: Use of Cardiac Electron Beam Computed Tomography 
(EBCT) and Magnetic Resonance Imaging (MRI) in Epidemiologic Studies 
of Cardiovascular Disease.
    Dates of Meeting: June 28, 1996.
    Time of Meeting: 8:30 a.m.
    Place of Meeting: Two Rockledge Center, 6701 Rockledge Drive, 
Conference Room 9A2, Bethesda, Maryland 20892.
    Agenda: To evaluate the use of EBCT and MRI of the heart in 
population-based studies for future initiatives.
    Contact Person: Diane Bild, M.D./Ph.D., NHLBI/DECA, Two 
Rockledge Center, 6701 Rockledge Drive, Rm. 8150, MSC 7934, 
Bethesda, Maryland 20892. (301) 435-0457.

(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart 
and Vascular Diseases Research; 93.838, Lung Diseases Research; and 
93.839, Blood Diseases and Resources Research, National Institutes 
of Health.)

    Dated: May 22, 1996.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 96-13369 Filed 5-28-96; 8:45 am]
BILLING CODE 4140-91-M
Beckstead and Watts, LLP
Certified Public Accountant
                                                       3340 Wynn Road Suite C
                                                          Las Vegas, NV 89102
                                                                 702.257.1984
                                                             702.362.0540 fax





March 27, 2003


To Whom It May Concern:

The firm of Beckstead and Watts, LLP, consents to the inclusion of our report
of  March  27, 2003, on the Financial Statements of Calif Acquisitions,  Inc.
for the years ended December 31, 2002 and 2001, in its Form 10K-SB filing  to
be filed with the US Securities and Exchange Commission.

Signed,


/s/ Beckstead and Watts

Beckstead and Watts, LLP
**EXHIBIT 32**

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Accessory Specialists Incorporated (the "Company") on Form 10-KSB for the period ended December 31, 2005, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Anthony N. DeMint, President and Chief Accounting Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

|   | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------|

 

|   | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------|

 

 

|   | /s/ Anthony N. DeMint                         |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | Anthony N. DeMint                                                                                                                                                     |
|   | President and Chief Accounting Officer                                                                                                                                |
|   | January 26, 2007

                                                                                                                                               |
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

In accordance with 18 U.S.C. §1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, Charles A. Carroll, President and Chief Executive Officer of Goodman Global, Inc. (the Registrant) and Lawrence M. Blackburn, Executive Vice President and Chief Financial Officer of the Registrant, each hereby
certifies that, to the best of his knowledge:



| | 1. | the Registrants Quarterly Report on Form 10-Q for the period ended June 30, 2007, to which this Certification is attached as Exhibit 32.1 (the Periodic
Report), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Periodic Report fairly presents, in all material respects, the financial condition of the Registrant at the end of the period covered by the
Periodic Report and results of operations of the Registrant for the periods covered by the Periodic Report.
| | -- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



By:

/s/ Charles A. CarrollCharles A. CarrollPresident and Chief Executive OfficerBy:

/s/ Lawrence M. BlackburnLawrence M. BlackburnExecutive Vice President and Chief Financial Officer


Date: August 8, 2007
1

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

JON M. SANDS

Federal Public Defender

JAMES D. SMITH

Assistant Federal Public Defender

State Bar No. 024194

407 W. Congress St., Suite 501

Tucson, AZ 85701

Telephone: (520) 879-7500

james_d_smith@fd.org

Attorney for Defendant

IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF ARIZONA

UNITED STATES OF AMERICA,

Plaintiff,

 vs.

SONIA QUINTERO,

 Defendant.

No. CR 17-1895-TUC-JAS (BPV)

ADDENDUM TO DEFENDANT’S 

OBJECTION FILED ON 

FEBRUARY 21, 2019

On February 28, 2019 the Court order that Ms. Quintero provide information

regarding an out-of-custody restoration program, and address self-surrender. 

Out-of-Custody Restoration

Ms. Quintero talked with Dr. Leslie Kirby at Kirby Psychological Services located 

in the Phoenix area, and talked with Dr. Katrina Buwalda at Buwalda Psychological 

Services who is also in Phoenix. Both doctors have a contract with the Maricopa County 

Superior Court to provide out-of-custody restoration counseling through a superior court 

approved program. Both doctors are able to accept Ms. Quintero into their out-of-custody 

restoration programs. Due to geographic location, Ms. Quintero asks that the Court order 
2

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

that she be treated by Dr. Kirby. The Federal Public Defender will arrange and pay for 

Ms. Quintero to be treated. 

Self-Surrender

Ms. Quintero has no means to transport herself to a mental health facility should 

the Court order that she be detained in a federal mental health institution. As such, she 

does not ask that she be allowed to report directly to a facility; however, she asks that she 

be allowed to surrender herself a day before she would be scheduled to be transported to 

the federal facility. 

RESPECTFULLY SUBMITTED: March 5, 2019 

JON M. SANDS

Federal Public Defender

s/ James D. Smith

JAMES D. SMITH

Assistant Federal Public Defender

The above signed does hereby certify that on the above date he electronically transmitted 

this document to the Clerk’s Office using the CM/ECF System for filing and transmittal of 

a Notice of Electronic Filing to the following CM/ECF registrants:

Sarah Houston

Assistant United States Attorney
**EXHIBIT 31.2**

**CERTIFICATION OF CHIEF FINANCIAL OFFICERPURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I,David B. Christofferson, certify that:

1.                 I have reviewedthis report on Form 10-Q of Venoco, Inc. (“Registrant”);

2.                 Based on myknowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, inlight of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

3.                 Based on myknowledge, the financial statements, and other financial information includedin this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the Registrant as of, andfor, the periods presented in this report;

4.                 The Registrant’sother certifying officer and I are responsible for establishing and maintainingdisclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the Registrant and have:

a)               designed suchdisclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that materialinformation relating to the Registrant, including its consolidated subsidiaries,is made known to us by others within those entities, particularly during theperiod in which this report is being prepared;

b)              evaluated theeffectiveness of the Registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

c)               disclosed in thisreport any change in the Registrant’s internal control over financial reportingthat occurred during the Registrant’s most recent fiscal quarter (theRegistrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, theRegistrant’s internal control over financial reporting; and

5.                 The Registrant’sother certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the Registrant’sauditors and the audit committee of Registrant’s board of directors (or personsperforming the equivalent functions):

a)               all significantdeficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adverselyaffect the Registrant’s ability to record, process, summarize and reportfinancial information; and

b)              anyfraud, whether or not material, that involves management or other employees whohave a significant role in the Registrant’s internal control over financialreporting.
| /s/  DAVID B. CHRISTOFFERSON |   |
|------------------------------|--------|
| David B. Christofferson      |
| *Chief Financial Officer*    |
| August 15, 2005         |

 

----
**EXHIBIT
      32.2**





**CERTIFICATION
      OF INTERIM CHIEF FINANCIAL OFFICER**


**PURSUANT
      TO 18U.S.C. SECTION 1350**





In
      connection with the Quarterly Report of The OLB Group, Inc. (the "Company")
      on
      Form 10-QSB for the period ending June 30, 2008 as filed with the Securities
      and Exchange Commission on the date hereof (the "Report"), I, Ronny Yakov,
      Interim Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
      ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act,
      that:





(1)
      The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and result of operations of the Company.




By:
            /s/ Ronny
                YakovRonny
                Yakov**,**Interim****Chief
                Financial OfficerNovember 10, 2008
#### STATE of Missouri, Respondent, v. Michael GARCIA, Appellant. Michael GARCIA, Appellant, v. STATE of Missouri, Respondent.

Nos. WD 49378, WD 50802.

Missouri Court of Appeals, Western District.

Nov. 14, 1995.

James C. Cox, Assistant Appellant Defender, Kansas City, for appellant.

Jeremiah W. (Jay) Nixon, Attorney General and Traci J. Sanders, Assistant Attorney General, Jefferson City, for respondent.

Before SPINDEN, P.J., and BRECKENRIDGE and SMART, JJ.

*ORDER*

PER CURIAM:

Michael Garcia was convicted of two counts of selling a controlled substance, § 195.211, RSMo 1994, and sentenced as a prior offender to two concurrent ten-year terms of imprisonment. He now appeals, claiming that the trial court committed plain error by allowing evidence of other crimes, and that the trial court erred by refusing to allow him to cross-examine a police detective as to whether the detective had ever made an erroneous identification. Mr. Garcia also appeals from the denial of his untimely Rule 29.15 motion for post-conviction relief.

The judgments of the trial court and the motion court are affirmed. Rules 30.25(b) and 84.16(b).
EXHIBIT 32.01


SANGUI BIOTECH INTERNATIONAL,
INC.




A COLORADO
CORPORATION




CERTIFICATION OF CHIEF EXECUTIVE
OFFICER AND CHIEF FINANCIAL OFFICER
 PURSUANT TO
 18 U.S.C. SECTION
1350,
 AS ADOPTED PURSUANT
TO
 SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002


In
connection with the Annual Report of Sangui Biotech International Inc. (the
“Company”) on Form 10-KSB/A for the period ended June 30, 2007 as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), I, Thomas
Striepe, Chief Executive Officer, and I, Joachim Fleing, Chief Financial
Officer, certify, pursuant to 18 U.S.C. §§ 1350, as adopted pursuant to §§ 906
of the Sarbanes-Oxley Act of 2002, that to the
best of my knowledge and belief:





(1)
            The
      Report fully complies with the requirements of section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and





(2)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.





A signed
original of this written statement required by Section 906, or other document
authentication, acknowledging, or otherwise adopting the signature that appears
in typed from within the electronic version of this written statement required
by Section 906, has been provided to Sangui Biotech International Inc., and will
be retained by Sangui Biotech International Inc. and furnished to the Securities
and Exchange Commission or its staff upon request.







Dated:
October 15, 2008       /s/ Thomas
Striepe
 __________________________________________
 By:
Thomas Striepe
 Chief
Executive Officer
   Dated:
October 15, 2008       /s/ Joachim
Fleing
 __________________________________________
 By:
Joachim Fleing
 Chief
Financial Officer
##### 



SUMMARY OF
DDi CORP.
2007 SENIOR MANAGEMENT BONUS PROGRAM
 1. Purpose and Effective Date .
 2. Eligibility and Participation .
 3. Performance Bonus .
 Administration of Bonus Program
 Target EBITDA Bonuses
 1




---



##### 



Appendix A
 Target Performance Bonuses Appendix A
 Committee Discretion
 Form and Time of Payment.
 Satisfactory Performance Required.
 Corporate Transactions and Change of Control
 2




---



##### 



4. Termination of Participation
 Events.
 (i)
    
    Involuntary termination of employment;(ii)
    
    Voluntary Resignation;(iii)
    
    Death; or(iv)
    
    Disability.
 Effect of Termination For Cause or Resignation without Good Reason.
 Effect of Other Events; Pro Rata Payments.
 Termination by the Company for reasons other than Cause, Termination because of Death or
Disability, or Resignation For Good Reason.
  3




---



##### 



Employees on Leave.
 Promoted Employees.
   (A)
    
    willful refusal to perform, in any material respect, his or her
duties or responsibilities for the Company;(B)
    
    material breach of his or her duties or responsibilities to the
Company;(C)
    
    gross negligence or willful disregard in the performance of his
or her duties or responsibilities;(D)
    
    willful disregard, in any material respect, of any financial or
other budgetary limitations established in good faith by the Board of Directors
of the Company, if continuing after written notice;(E)
    
    engaging in conduct that causes material and demonstrable
injury, monetarily or otherwise, to the Company, including, but not limited to,
misappropriation or conversion of the Companys assets; or(F)
    
    conviction of or entry of a plea of nolo contendereto a
felony.
 4
        5. Binding Authority .
 6. Source of Payments .
 7. Amendment or Termination .
 8. Severability .
 9. No Employment Rights .
 10. Transferability of Rights. 5
       11 Governing Law.
 6




---



##### 



Appendix A
 Target EBITDA Bonus Percentage
 Net EBITDA %
    
    % of Target EBITDA Bonus< 70%
    
    
    0
    %3 70%, but < 75%
    
    
    0.0
    %3 75%, but < 80%
    
    
    35.0
    %3 80%, but < 85%
    
    
    47.5
    %3 85%, but < 90%
    
    
    65.0
    %3 90%, but < 95%
    
    
    75.0
    %3 95%, but < 100%
    
    
    85.0
    %3 100%, but <105%
    
    
    100
    %3 105%, but <110%
    
    
    115.0
    %3 110%, but <120%
    
    
    125.0
    %3 120%
    
    
    200
    %
 Target Bonus Performance Percentage
 Net EBITDA %
    
    % of Target Performance Bonus< 50%
    
    
    0
    %3 50%, but < 60%
    
    
    50
    %3 60%, but < 70%
    
    
    75
    %3 70%
    
    
    100
    %
 1
[Federal Register Volume 61, Number 101 (Thursday, May 23, 1996)]
[Notices]
[Page 25920]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-13005]



=======================================================================
-----------------------------------------------------------------------

NATIONAL SCIENCE FOUNDATION


Special Emphasis Panel in Bioengineering and Environmental 
Systems; Notice of Meeting

    In accordance with the Federal Advisory Committee Act (Pub. L. 92-
463, as amended), the National Science Foundation announces the 
following meeting.

    Name: Special Emphasis Panel in Bioengineering and Environmental 
Systems (No. 1189).
    Date and Time: June 12, 1996; 8:30 am-5:00 pm.
    Place: National Science Foundation, 4201 Wilson Boulevard, Room 
565, Arlington, VA 22230.
    Type of Meeting: Closed.
    Contact Person: William A. Weigand, Program Director, 
Biochemical Engineering, Division of Bioengineering and 
Environmental Systems, National Science Foundation, 4201 Wilson 
Boulevard, Arlington, VA 22230, Telephone: (703) 306-1318.
    Purpose of Meeting: To provide advice and recommendations 
concerning proposals submitted to NSF for financial support.
    Agenda: To review and evaluate the 1996 Group proposals as part 
of the selection process for awards.
    Reason for Closing: The proposals being reviewed include 
information of a proprietary or confidential nature, including 
technical information; financial data, such as salaries; and 
personal information concerning individuals associated with the 
proposals. These matters are exempt under 5 U.S.C. 552b(c), (4) and 
(6) of the Government in the Sunshine Act.

    Dated: May 20, 1996.
M. Rebecca Winkler,
Committee Management Officer.
[FR Doc. 96-13005 Filed 5-22-96; 8:45 am]
BILLING CODE 7555-01-M